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Abstract
Background: The aim was to determine the accuracy of high-resolution ultrasonography (US) for detecting
erosion in the metacarpophalangeal (MCP) and wrist joints of patients with different subtypes of systemic
lupus erythematosus (SLE) arthritis, using computed tomography (CT) as the gold-standard reference method.
Method: The ulnar head, radiocarpal and second to fifth MCP joints in 26 patients with SLE - 9 classified as
having rhupus syndrome, 10 as having Jaccoud’s arthropathy (JA) and 7 as having non-deforming non-erosive
(NDNE) arthritis - were subdivided into areas and bilaterally evaluated for the presence of bone erosion by CT
and US. On CT, erosion volume was scored according to the outcome measures in rheumatology-rheumatoid
arthritis magnetic resonance imaging (OMERACT-RAMRIS) score. On US, erosions were semi-quantitatively scored
0–3 according to scoring by ultrasound structural erosion (ScUSSe) systems.
Results: Erosions were detected by CT in 92/728 areas (12.6 %) and by US in 43/728 areas (5.9 %). Sensitivity,
specificity and accuracy of US overall was 36 %, 98 % and 90 % compared with 57 %, 98 % and 93 % in the
dorsal and lateral aspects of the second and fifth MCP, which were identified as areas with the best US reliability.
Adding wrist joints would capture a larger number of erosions without affecting the accuracy. US detected
90.0 % of CT erosions with bone volume loss >20 % and 51.2 % of erosions with bone volume loss >10 %.
Patients with rhupus had a greater number of larger erosions than those with JA or NDNE arthritis, with
prevalent involvement of the MCP joints. Overall reliability of US in detecting bone erosions was moderate
for rhupus syndrome (0.55) and JA (0.58), but poor for NDNE arthritis (0.10).
Conclusion: US had moderate sensitivity and excellent specificity for detection and semi-quantitative
assessment of bone erosions in SLE.
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Background
Arthritis in systemic lupus erythematosus (SLE) is usu-
ally non-erosive on x-ray, even in the 5–15 % of pa-
tients with long-standing disease who develop hand
and foot deformities as hallmarks of Jaccoud’s arthropa-
thy (JA) [1, 2]. An exception is represented by rhupus
syndrome, which affects fewer than 5 % of patients and
is characterized by erosions on radiographs of the
hands and feet, persistent synovitis and a high titer of
anti-cyclic citrullinated peptide (aCCP) antibodies, and
may be considered an overlap between rheumatoid
arthritis (RA) and SLE [3, 4]. The increased number of
reports on rhupus syndrome may have also influenced
the 2012 Systemic Lupus International Collaboration
Clinics (SLICC) classification criteria statement that
some SLE arthritis may, in fact, be erosive [5]. Recent
ultrasonography (US) studies show an unexpected bur-
den of erosive damage, challenging the classification of
SLE arthritis as non-erosive, and also demonstrate that
US is more sensitive than conventional radiography in
detecting bone erosions in SLE [6–11]. However, great
variability in erosion rates (from 2 % to 41 %) has been
reported, probably because different joint sites were in-
cluded in the US protocols, and most studies did not
clearly separate patients with rhupus syndrome from
other patients with SLE [12]. US-detected bone ero-
sions are associated with future appearance of erosions
on radiography and worse prognosis in patients with
RA [13]. In contrast to RA, the nature and progression
of US-detected erosions in SLE is poorly understood
and whether erosions detected by US or radiography
imply a different course is yet unknown and deserves
further prospective studies [14].
A semi-quantitative scoring system has been devel-
oped to assess the size of US bone erosions [15] and
has been applied in RA [16, 17] but not in SLE. Fur-
thermore, the hand and wrist joints in which US per-
forms better in detecting bone erosions have never
been investigated in patients with SLE. US is increas-
ingly being used in daily practice and increasingly
features in scientific reports for the assessment of pa-
tients with SLE arthritis, therefore, it is of great interest
to evaluate the reliability and performance of US for
erosion detection in this disease. Computed tomog-
raphy (CT) has been shown to be the gold standard for
detecting erosions and therefore could be considered
the best reference method [18, 19].
The aims of the present study were, first, to evaluate
the sensitivity, specificity and accuracy of high-resolution
US in different areas of the wrist and hand joints in pa-
tients with SLE using multislice CT as the gold standard
reference method and, second, to evaluate the accuracy of
US and compare erosive features in the different subtypes
of SLE arthritis.
Methods
Study cohort
Imaging studies from 26 Caucasian patients with SLE
participating in a larger prospective study (the Sys-
temic Lupus Erythematosus Musculoskeletal Manifest-
ation Study (SLEMMS)) were used to compare the
detection of erosions in the wrist and metacarpopha-
langeal (MCP) joints using CT and US. All patients
were diagnosed as suffering with SLE according to the
1997 American College of Rheumatology (ACR) classi-
fication criteria and were further classified as suffering
with rhupus syndrome, JA or non-deforming and non-
erosive (NDNE) arthritis.
After classification according to the subtypes of SLE
arthritis, patients were consecutively enrolled into three
different subgroups: (1) rhupus syndrome, which was
defined by the presence of bone erosions on x-ray and
by fulfillment of classification criteria for both RA and
SLE; (2) JA, which was defined as the presence of one or
more of the following reducible or fixed hand deformities:
MCP subluxation, ulnar drift, swan neck or boutonniere
fingers and Z thumbs in the absence of x-ray-detected
erosions and (3) the remaining patients, who were clas-
sified as having NDNE arthritis.
Study inclusion criteria were: (a) ≥18 years old, (b) past
or present musculoskeletal inflammatory involvement and
(c) capable of giving consent. Exclusion criteria were: (a)
women who were pregnant or breastfeeding and (b)
women of child-bearing potential, or men whose partners
were women of childbearing potential and who were
unwilling to use effective contraception within ± 1 month
of undergoing CT.
US and CT acquisition and assessment
The ulnar head, radiocarpal and second to fifth metacar-
pal heads were bilaterally examined by CT and US in 26
patients, and were evaluated for the presence of bone
erosion in 14 areas on each side: (a) a dorsal and lateral
scan of the ulnar head and radiocarpal joint (including
the distal radial epiphysis, scaphoid and lunate bones);
(b) the dorsal, lateral and palmar aspect of the second
and fifth metacarpal head and (c) the dorsal and palmar
aspect of the third and fourth metacarpal head. US and
CT images were independently assessed by a rheuma-
tologist (AG) and a radiologist (LS), respectively, blinded
to clinical and other imaging data.
CT was performed on a 16-multi-detector-row CT
scanner (Philips Brilliance, Philips, Eindhoven Netherland).
Parameters used were voxel size 0.5 mm× 0.5 mm×
0.5 mm (isotropic voxel), pitch 0.5, slice spacing 0.5 mm,
overlap 50 %, 120 kV and 280 mAs. Images were recon-
structed in the coronal and axial planes with a slice
thickness of 0.5 mm. Erosion was defined as a sharply
juxta-articular marginated bone lesion, visible in two
Piga et al. Arthritis Research & Therapy  (2016) 18:222 Page 2 of 9
planes, and with a cortical break seen in at least one
plane. Moreover, CT images were scored for erosions
according to the outcome measures in rheumatology
(OMERACT)/rheumatoid arthritis magnetic resonance
imaging score (RAMRIS) method [20, 21]. According
to RAMRIS, bone erosion was graded by percentage
volume (0–10, by 10 % volume increments) of the
assessed bone. Each bone (in the wrists, the carpal
bones, distal radius, distal ulna and metacarpal bases;
in the MCP joints, the metacarpal heads and phalangeal
bases) is scored separately. The scale is 0–10, based on
the proportion of eroded bone compared to the “assessed
bone volume” judged on all available images (0 = no
erosion, 1 = 1–10 % of bone eroded, 2 = 11–20 %
eroded ; 3 = 21–30 % eroded, and so on). For metacar-
pal and phalangeal bone the “assessed bone volume” is
from the articular surface to a depth of 1 cm, and in
carpal bones it is the whole bone. In total 23 bone sites
are evaluated, leading to a total RAMRIS erosion score
ranging between 0 and 230 for each hand (80 for the
MCP and 150 for the wrist joints).
US examinations were performed using a Logiq9
(General Electric Medical Systems, WI, USA) equipped
with an 8 − 15 MHz (4D16L) volumetric probe (lateral
resolution = 0.3 mm, axial resolution = 0.1 mm). Patients
were seated with their hands positioned on an examining
table in supination for the volar scans and pronation for
the dorsal scans, with the wrist in a neutral position. Joints
were bilaterally evaluated using a multi-planar scanning
technique. According to OMERACT, US bone erosion
was defined as an intra-articular discontinuity of the bone
surface that is visible in two perpendicular planes [22]. In
addition to this categorical assessment (present/absent),
erosions were scored on a 0–3 scale in each joint area ac-
cording to the maximal length (0 = no erosion, 1 = <2 mm,
2 = 2–3 mm, 3 = >3 mm) as suggested by the scoring
ultrasound structural erosion (ScUSSe) system [15].
Statistical analysis
Relevant features were reported as mean ± standard
deviation (SD) or median (25th to 75th percentiles) for
normal or non-normal distributed variables, according
to the Kolmogorov-Smirnov test, and number with the
corresponding percentage. Student’s t test, or the Mann-
Whitney test if necessary, were used to compare the
distribution of quantitative variables in different sub-
types of SLE arthritis. Two-tailed p values <0.05 were
considered significant.
The sensitivity, specificity and accuracy (or exact agree-
ment) of US for detecting erosion in the hand and wrist
joints in patients with SLE were calculated using CT as
the reference method. This was repeated for each joint
and for each subtype of SLE arthritis. The agreement be-
tween CT and US was additionally evaluated by weighted
k values and by the proportion of US erosions confirmed
by CT. Reliability analysis of CT and US assessment was
evaluated by inter-observer agreement rates (k values)
with a second radiologist (AB) and another rheuma-
tologist (MP), respectively, both blinded to the other
imaging data. The radiologist made an assessment on
stored CT images, whereas the rheumatologist per-
formed an independent UD examination on the same
day. A weighted k value of 0–0.20 was considered poor,
0.21–0.40 fair, 0.41–0.60 moderate, 0.61–0.80 good and
0.81–1.00 excellent; the 95 % confidence interval (CI)
was also calculated. Statistical analyses were performed
using the software package MedCalc 15.0 (MedCalc
Software, Mariakerke, Belgium).
Results
The mean age of the enrolled patients was 49.4 ±
15.5 years with mean disease duration of 16.0 ± 8.2 years.
Among the enrolled patients, 9 out of 26 (34.6 %) were
classified as having rhupus syndrome, 10/26 (38.5) as
having JA and 7/26 (26.9 %) as having NDNE arthritis.
The patients’ demographic data are presented in Table 1.
Inter-observer agreement rates between the two sono-
graphers were excellent for erosion detection (k value =
0.86, 95 % CI 0.65, 0.98) and that between the two radi-
ologists was similar (k value = 0.84, 95 % CI 0.64, 0.97).
Detection of erosions by CT and US
Erosions were detected by CT in 92 out of 728 areas
(12.6 %) and by US in 43/728 areas (5.9 %) (Table 2).
With CT as the reference method, US had overall sensi-
tivity of 35.9 % and specificity of 98.7 % for the detection
of bone erosions in the hands in patients with SLE. The
exact agreement was 90.8 % with a moderate k value of
0.50 (95 % CI 0.36, 0.63). Values differed according to
the areas assessed, with the US having the highest sensi-
tivity in the dorsal and lateral aspect of the second and
fifth metacarpal heads (Table 2). When only the second
and fifth MCP areas were included the overall sensitivity
of US increased to 57.1 %, the specificity was 97.8 % and
accuracy 93.3 % (k value 0.66, 95 % CI 0.50, 0.83). If the
ulnar and radiocarpal areas were added to the second
and fifth MCP areas the sensitivity remained moderate
(45.7 %) with excellent specificity (98.4 %), excellent
accuracy (91.3 %) and good reliability (k value 0.63,
95 % CI 0.50, 0.75). Investigating the volar aspect of
MCP heads did not add value to the US examination,
as erosions in these quadrants were rare (0.9 %).
There were no major differences in the results for the
dominant and non-dominant hand. CT detected ero-
sions in 46 areas in both hands. The exact agreement
between CT and US was 91.5 % for the dominant hand
(k value = 0.50, 95 % CI 0.32, 0.69) and 90.1 % for the
non-dominant hand (k value = 0.49, 95 % CI 0.30, 0.68).
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Bone volume loss on CT and US
In 8 out of the 43 areas (18.6 %) with US-detected
erosions, the US erosions were not confirmed by
CT. These were located at the second MCP (n = 6),
third MCP (n = 1) and the ulnar head (n = 1) and all
of them were scored 1 using the ScUSSe. On re-
assessment of these areas the major confounding
reasons were cortical irregularities, osteophytes and
bone surface indentation at the metacarpal neck. In
one patient an erosion was detected on reassessment
by CT.
US detected 51.2 % of areas with erosions where the
bone volume loss detected by CT was >10 %, irrespect-
ive of the localization. When only the areas with the best
US reliability were included, that proportion increased
to 70.0 % (Table 3). There was only one large erosion at
the third MCP (grade 3) that was detected on CT but
not identified by US.
Table 1 Baseline demographic data and cumulative clinical and serological data of the study cohort
SLE (n = 26) Rhupus syndrome (n = 9) Jaccoud’s arthropathy (n = 10) NDNE (n = 7)
Age (mean ± SD) 49.4 ± 16.0 41.1 ± 5.7 61.3 ± 14.3 43.1 ± 16.5
Disease duration (mean ± SD) 15.6 ± 8.2 13.7 ± 6.7 21.7 ± 8.5 10.8 ± 4.5
Gender, female, n 26 9 10 7
Cumulative 1997 ACR criteria
Malar rash 12 (46.2) 5 (55.5) 4 (40.0) 3 (42.8)
Discoid rash 2 (7.7) 0 1 (10.0) 1 (14.3)
Photosensitivity 4 (15.4) 1 (11.1) 2 (20.0) 1 (14.3)
Oral/nasopharyngeal ulcers 2 (7.7) 0 1 (10.0) 1 (14.3)
Serositis 15 (57.7) 4 (44.4) 8 (80.0) 3 (42.8)
Renal disorders 5 (19.2) 0 2 (20.0) 3 (42.8)
Neurologic disorders 2 (7.7) 0 2 (20.0) 0
Hematological disorders 14 (53.8) 5 (55.5) 7 (70.0) 2 (28.6)
ANA 26 (100) 9 (100) 10 (100) 7 (100)
Anti-dsDNA 18 (69.2) 6 (66.7) 8 (80.0) 4 (57.1)
Antiphospholipid antibodies 7 (26.9) 3 (33.3) 3 (30.0) 1 (14.3)
Other laboratory findings
Anti-Ro/SSA 14 (53.8) 4 (44.4) 5 (50.0) 5 (71.4)
Anti-La/SSB 2 (7.7) 0 1 (10.0) 1 (14.3)
Anti-RNP 2 (7.7) 0 0 2 (28.6)
Anti-Sm 2 (7.7) 0 0 2 (28.6)
Rheumatoid factor 11 (37.9) 7 (77.8) 1 (10.0) 3 (42.8)
Anti-CCP 7 (26.9) 6 (66.7) 0 1 (14.3)
SLICC/damage index (mean ± SD) 1.4 ± 1.3 1.4 ± 0.5 2.6 ± 1.3 0.6 ± 0.5
Medication receiveda
Total corticosteroid dose >50 g 15 (57.7) 3 (33.3) 10 (100) 2 (28.6)
Antimalarial agents 25 (96.1) 8 (88.9) 10 (100) 7 (100)
Methotrexate 20 (76.9) 9 (100) 6 (60.0) 5 (71.4)
Azathioptine 7 (26.9) 1 (11.1) 4 (40.0) 2 (28.6)
Micophenolate 4 (15.4) 1 (11.1) 1 (10.0) 2 (28.6)
Rituximab 8 (30.7) 4 (44.4) 2 (20.0) 2 (28.6)
Belimumab 1 (3.8) 0 0 1 (14.3)
Anti TNF-alpha 3 (11.5) 3(33.3) 0 0
Anti IL-6 2 (7.7) 1 (11.1) 1 (10.0) 0
Unless otherwise specified, values are the number of patients (values in brackets are percentage). aIncludes medication ongoing at enrollment and past treatment.
Antiphospholipid antibodies included lupus anticoagulant, anticardiolipin antibodies IgG and IgM, beta2-glicoproteinI IgG and IgM. Anti-extractable nuclear antigens
(SSA, SSB, Sm, RNP, Rheumatoid factor and anti-cyclic citrullinated peptide antibodies (antiCCP) were tested by ELISA. Antinuclear antibodies (ANA) were tested by IIF,
using Hep2 cell substrate; positivity was defined as a titer ≥1:320. Anti-double-stranded DNA (Anti-dsDNA) antibodies were tested by Farr assay. SLE systemic
lupus erythematosus, NDNE non-deforming non-erosive, ACR American College of Rheumatology, SLICC Systemic Lupus International Collaboration Clinics
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Subtypes of SLE arthritis
Erosions were detected by US in 9/9 patients with rhupus
(100 %), 5/10 patients with JA (50.0 %) and 3/7 patients
with NDNE (42.8 %). Patients with rhupus syndrome had
larger numbers of erosions and higher ScUSSe grades of
erosion than patients with JA and NDNE (Table 4). The
most frequent localization of US-detected erosion in
rhupus syndrome was at the second MCP (90.0 %)
(Fig. 1) and the fifth MCP joints (44.4 %) and the wrist
joint (44.4 %). The second MCP and wrist joints were
equally affected by erosion in JA (30.0 %) and NDNE
arthritis (28.6 %).
Using CT as the reference method, the overall reliability
of US in detecting bone erosions was moderate for rhupus
syndrome (k value = 0.55, 95 % CI 0.38, 0.71) and JA (k
value = 0.58, 95 % CI 0.32, 0.83), whereas it was poor for
NDNE arthritis (k value = 0.10, 95 % CI 0.05, 0.26).
Erosions were detected by CT in 9/9 patients (100 %)
with rhupus syndrome, 8/10 patients (80.0 %) with JA
and 5/7 patients (71.4 %) with NDNE arthritis. The
median RAMRIS score for erosions was 10.0 (1.0–15.0).
CT-detected erosions were more frequently identified in
the wrist (in rhupus syndrome 9/9 (100 %), in JA 7/10
(70.0 %) and in NDNE arthritis 5/7 (71.4 %) than in
the MCP joints (in rhupus syndrome 8/9 (88.8 %), in
JA 6/10 (60.0 %) and in NDNE arthritis 2/7 (28.6 %).
The burden of damage calculated by RAMRIS erosion
score was differently distributed, being significantly higher
at the MCP joints in patients with rhupus syndrome than
Table 2 Distribution of erosions in different region of interest according to CT and US, and sensitivity, specificity, accuracy and k
values for high-resolution US in detecting erosion (grading from 0 to 3) at different joint sites using CT as the reference method
Quadrants CT-detected
erosions
US-detected
erosions
Sensitivity (%) Specificity (%) Exact agreement (%) k values (95 % CI)
Second metacarpal head 156 27 (17.3) 21 (13.5) 51.9 95.3 87.8 0.63 (0.43 to 0.83)
Dorsal 52 16 (30.8) 13 (25.0) 56.3 88.9 78.8 0.51 (0.26 to 0.75)
Lateral 52 11 (21.2) 8 (15.4) 54.5 95.1 86.5 0.77 (0.54 to 1.00)
Volar 52 0 0 NC NC NC NC
Third metacarpal head 104 15 (14.4) 4 (3.8) 20.0 98.9 87.5 0.26 (0.03 to 0.48)
Dorsal 52 14 (21.2) 4 (15.4) 21.4 97.4 76.9 0.24 (0.02 to 0.46)
Volar 52 1 (1.9) 0 0 100 98.1 0 (0.00 to 0.00)
Fourth metacarpal head 104 7 (6.7) 1 (0.9) 14.3 100 94.2 0.19 (-0.12 to 0.51)
Dorsal 52 6 (11.5) 1 (1.9) 17.0 100 90.4 0.08 (-0.09 to 0.26)
Volar 52 1 (1.9) 0 0 100 98.1 0 (0.00 to 0.00)
Fifth metacarpal head 156 8 (5.1) 6 (3.8) 50.0 100 96.3 0.77 (0.66 to 0.89)
Dorsal 52 6 (11.5) 4 (7.7) 66.7 100 96.2 0.73 (0.56 to 0.90)
Lateral 52 2 (3.8) 2 (3.8) 100 100 100 0.85 (0.74 to 0.97)
Volar 52 0 0 NC NC NC NC
Radiocarpal 104 18 (17.3) 6 (5.8) 33.0 100 88.5 0.57 (0.30 to 0.83)
Dorsal 52 15 (28.8) 4 (7.7) 26.7 100 78.8 0.48 (0.16 to 0.80)
Lateral 52 3 (5.7) 2 (3.8) 66.7 100 98.1 0.79 (0.39 to 1.0)
Ulnar head 104 17 (16.3) 5 (4.8) 23.5 98.9 86.5 0.29 (0.05 to 0.54)
Dorsal 52 13 (25.0) 4 (7.7) 23.1 97.4 78.8 0.23 (-0.03 to 0.50)
Lateral 52 4 (7.7) 1 (1.9) 25.0 100 94.2 0.38 (-0.15 to 0.91)
Total 728 92 (12.6) 43 (5.9) 35.9 98.7 90.8 0.50 (0.36 to 0.63)
Unless otherwise specified, values are the number of patients (values in brackets are percentage). CT computed tomography, US ultrasound, NC not computable
Table 3 Erosions detected by CT in joint quadrants and semi-
quantitatively assessed according to the RAMRIS erosion score,
and proportion of erosions detected by US
RAMRIS erosion score Quadrants with
CT erosion (n)
US-detected
erosions (%)
All areas
Grade 1 (1–10 %) 51 27.5
Grade 2 (11 − 20 %) 31 41.9
Grade 3 − 10 (21–100 %) 10 90.0a
Areas with best US reliabilityb
Grade 1 (1 − 10 %) 15 53.3
Grade 2 (11 − 20 %) 15 60.0
Grade 3 − 10 (21 − 100 %) 5 100.0
aOnly one large computed tomography (CT)-detected erosion (grade 3) at
the third metacarpophalangeal join (MCP) was not identified by ultrasound
(US) because the cortical break was not accessible to US. bSecond MCP and
fifth MCP quadrants. RAMRIS rheumatoid arthritis magnetic resonance
imaging score
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in patients with JA and NDNE arthritis (Table 4). No major
differences were found between JA and NDNE arthritis.
Discussion
This is the first study to date assessing the bone erosive
burden in patients with SLE by using semi-quantitative
US and CT scoring systems and defining the accuracy of
US in detecting bone erosions in the hands and wrists of
patients with SLE, using CT as the reference method. In
the present study US had very high specificity (98.7 %)
and fair sensitivity (35.9 %) for detecting erosions when
compared to CT. US had fair sensitivity of 23.5 % in the
wrist joint but when only the MCP joints were included
in the analysis, the sensitivity increased to 40.4 %, and
by further restricting analysis to the second and fifth
MCP joints, which are considered the areas with the
best US reliability, sensitivity increased to 57.1 %.
These findings are in agreement with the results from
CT studies performed on MCP joints in patients with
RA, showing overall moderate sensitivity of 42–44 %
[16, 18]. However, Dohn et al. reported sensitivity of
71 % when investigating areas with the best US accessi-
bility [16]. The lower US sensitivity observed in the
present study could be due to poor ability to detect
small erosions in patients with non-rhupus SLE, com-
pared to that observed in RA. In magnetic resonance im-
aging (MRI) studies in SLE, MCP joint erosions have been
detected in 47–61 % of patients and wrist joint erosions
have been detected in 82 − 99 % of patients [9, 23–25],
which roughly corresponds to our results, with 61.5 % and
80.7 % of patients with CT-detected erosions detected in
the MCP and wrist joints, respectively. Compared with
CT and MRI, the performance of US was confirmed to be
worse for detection of erosions, especially when assessing
Table 4 Main characteristics and distribution of US and CT abnormalities in patients with different subtypes of SLE arthropathy
Rhupus (n = 9) JA (n = 10) NDNE (n = 7) Rhupus vs JA
(p value)
Rhupus vs NDNE
(p value)
JA vs NDNE
(p value)
Age, years (mean ± SD) 41.0 ± 5.7 61.3 ± 14.3 43.1 ± 16.4 0.001 0.765 0.035
Disease duration, years (mean ± SD) 13.7 ± 6.6 21.7 ± 10.7 10.8 ± 4.1 0.035 0.298 0.003
Rheumatoid factor 7 (77.8 %) 2 (20.0 %) 2 (28.5 %) - - -
Anti-CCP 6 (66.7 %) 0 (0) 1 (14.2 %) - - -
US erosion number (median (25th to 75th percentile)) 3.0 (1.7–4.2) 0.5 (0–2.0) 0 (0–1.0) 0.019 0.004 0.569
US quadrants with erosion 27 (10.7 %) 12 (4.3 %) 4 (2.0 %) - - -
ScUSSe total (median (25th to 75th percentile)) 4.0 (2.5–6.0) 1.0 (0–3.0) 0 (0–1.0) 0.021 0.003 0.535
Grade 1 (<2 mm) 16a 10a 4a - - -
Grade 2 (2–3 mm) 9a 1a 0a - - -
Grade 3 (>3 mm) 2a 1a 0a - - -
CT erosion number (mean ± SD) 14.0 ± 9.7 5.7 ± 5.1 4.7 ± 4.5 0.050 0.030 0.543
RAMRIS (mean ± SD) 21.6 ± 18.2 7.4 ± 7.0 5.1 ± 5.0 0.053 0.029 0.448
RAMRIS MCP (median (25th to 75th percentile)) 6.0 (4.5–10.2) 1.0 (0–2.0) 0 (0–1.5) 0.013 0.009 0.353
RAMRIS wrist (median (25th to 75th percentile)) 8.0 (10.2–16.2) 3.5 (0–11.0) 3.0 (0.5–6.7) 0.111 0.057 0.694
Grade 1 (1–10 %) 24a 21a 6a - - -
Grade 2 (11–20 %) 19a 6a 6a - - -
Grade 3 − 10 (21–100 %) 7a 1a 2a - - -
Numbers in bold indicate statistical significance for p <0.05. Boxes are empty where statistics was not applied
aAbsolute numbers referring to joint quadrants. JA Jaccoud’s arthropathy, NDNE non-deforming non-erosive, Anti-CCP anti-cyclic citrullinated peptide, US ultrasound, ScUSSe
scoring ultrasound structural erosion, CT computed tomography, RAMRIS rheumatoid arthritis magnetic resonance imaging score, MCP metacarpophalangeal joint
Fig. 1 Bone erosions in a patient with rhupus syndrome. Longitudinal
ultrasound image of the second metacarpophalangeal joint lateral area
showing a grade-2 scoring ultrasound structural erosion (arrow) with
sharp margins (a) corresponding to a grade-2 rheumatoid arthritis
magnetic resonance imaging score erosion (arrow) visible in the
computed tomography coronal scan of the hand (b). MH second
metacarpal head, PP second proximal phalanx
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the wrist. In fact, in this and previous US studies [6–9] the
incidence of wrist erosions was lower (4 − 20 %) than that
of MCP erosions (20 − 41 %), in contrast to what has been
shown by CT and MRI.
The distribution of erosive damage could be of par-
ticular interest in differentiating between subtypes of
SLE arthritis. Tani and colleagues [26] showed that the
cumulative burden and distribution of MRI-detected
erosions in rhupus syndrome were similar to those in
RA and significantly higher than in non-rhupus SLE. We
further characterized these features proving that both
US and CT detected a higher proportion of grade-2 and
grade-3 erosions in rhupus syndrome than in patients
with JA and NDNE arthritis. Noteworthy, patients with
rhupus syndrome had a significantly higher burden of
erosive damage in the MCP joints than those with JA
and NDNE arthritis detected by both CT and US, but no
significant differences were found in the wrist joints.
Along with these novel observations, we provide data
on the largest series published so far of US assessment
of the hands in JA. By contrast to our previous experience,
reporting US erosions in 16.7 % (1 out of 6) of patients
with JA [6], in the present study the prevalence of erosions
detected by US and CT was 50.0 % and 80.0 %, respect-
ively. This is similar to that reported by Sa Ribeiro and
colleagues [27], showing MRI-detected MCP erosions in
50.0 % of patients with JA. These contrasting results could
be due to the different joint sites investigated in our
previous study [6], which included areas with low US
sensitivity such as the third MCP joint and the wrist,
and, by contrast, did not assess the fifth MCP joint.
Moreover, the erosive damage in both JA and NDNE
arthritis did not resemble that seen in rhupus syndrome
and RA. Previously published studies do not report
“hook” erosions in RA [15–21, 23], which are instead
considered a hallmark of JA [2, 24, 28]. Although the
analysis of hook erosions in the different subtypes of
SLE arthritis was not an objective of this study, we found
that only the large erosions detected by US and CT in
patients with JA had a well-defined hook-shaped de-
formity with a sclerotic margin (Fig. 2) replicating, in
fact, the hook erosions rarely seen on radiographs [28].
Erosions observed in patients with NDNE arthritis were
actually fewer and smaller than in rhupus syndrome
and JA, which could explain why the sensitivity and re-
liability of US in this group of patients was poor using
CT as the gold standard reference method. Further
studies, aimed at comparing erosions in the different
subtypes of SLE arthritis, are needed, as our findings
might be related to the small sample size, representing
a major limitation; however, this was a secondary ob-
jective of the study.
The present study has some other limitations. First,
ScUSSe and RAMRIS were not specifically developed for
use in patients with SLE and are based on different defi-
nitions and erosion scoring, which may have influenced
the agreement between the two methods. Nevertheless,
using existing scoring systems makes the results com-
parable to other RA and SLE studies. Second, the rate
of erosion reported in present study may have been
affected by differences in and time to initiation of con-
comitant and prior treatment. It is worth noting that
the only significant treatment difference between the
subgroups of patients was a higher cumulative dose of
steroid registered in patients with JA, which has been
recently envisaged as a major cause of joint laxity and
Fig. 2 Bone erosions in patients with Jaccoud’s arthropathy. Longitudinal ultrasound (US) image of the lateral ulnar head area (U) showing a
grade-2 scoring ultrasound structural erosion (ScUSSe) (arrow) with a hook-shaped deformity (arrow head) (a). U ulnae, R radial, *extensor carpi
ulnaris tendon. Coronal computed tomography (CT) scan of the wrist showing a grade-4 rheumatoid arthritis magnetic resonance imaging
score (RAMRIS) erosion (arrow) confirming the hook-shaped deformity (arrow head) with a bony sclerotic margin (b). Transversal US view of
the second metacarpophalangeal (MCP) dorsal area showing a grade-3 ScUSSe hook-shaped (arrow head) erosion (arrow) (c) corresponding to
a grade 3 RAMRIS score erosion (arrow) with hook-shaped deformity (arrow head) visible in the CT coronal scan of the hand (d). MH second
metacarpal head
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development of deformities in patients with SLE [14].
Finally, a comparison of US, CT, and conventional radi-
ography was not performed. This could be considered a
limitation; however, radiography has low sensitivity for
the detection of bony erosive damage in SLE [1, 6, 14, 29]
and for classification of patients [1, 25, 26], and therefore,
it should be limited to first-line assessment and for
differential diagnosis.
Conclusions
Overall, the most important message to emerge from the
present study is that US detection of bone erosions in pa-
tients with SLE has very high specificity and also moderate
sensitivity when restricted to the second and fifth MCP
joints, which are the joints that can be assessed with high
reliability. Adding the wrist joint will enhance the ability to
identify a greater number of erosions, preserving good reli-
ability and only weakly affecting the accuracy. Even though
it is still not possible to make an early differentiation
between SLE arthritis subtypes using US exclusively, the
high specificity of US for detecting bone erosions suggests
that it may play a role in the future in early classification of
different SLE arthritis subtypes. A classification system
could be particularly helpful in order to provide targeted
therapies to patients at risk of developing erosive or
deforming arthritis as a major cause of disability. An in-
creasing number of scientific reports suggest, in fact, that
patients with rhupus syndrome may take advantage of anti-
CD20 [30] or anti-CTL4 [31] biologic drugs, whereas TNF-
alpha blockers are discouraged [32]. On the other hand, JA
has been suggested to be a late complication of NDNE
arthritis, characterized by high IL-6 and C-reactive protein
and sub-clinical inflammation [11, 14, 33], and therefore,
may benefit from early anti-BLyS [34] or anti-IL-6 treat-
ment. In conclusion, further studies aimed at outlining a
classification system and shedding some light on the mech-
anisms underlying the development and progression of US-
detected erosions in SLE must assess the erosive changes
using a semi-quantitative scoring system, and must focus
on the second and fifth MCP and wrist joints in order to
ensure the highest sensitivity and specificity and capture
the higher burden of erosive damage.
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